Spray-drying of air-liquid interface sensitive recombinant human growth hormone

被引:146
作者
Maa, YF [1 ]
Nguyen, PAT [1 ]
Hsu, SW [1 ]
机构
[1] Genentech Inc, Pharmaceut Res & Dev, San Francisco, CA 94080 USA
关键词
D O I
10.1021/js970308x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Spray-drying is an attractive method for preparing fine recombinant human growth hormone (rhGH) powders if the detrimental effect of protein degradation at the air-liquid interface on the protein can be minimized. In this study, we demonstrated that rhGH degradation (insoluble and soluble aggregate formation), as the consequence of air-liquid interfacial degradation, could be prevented using the appropriate formulation. Adding polysorbate-20 surfactant into the liquid feed (with no presence of sugar protectant) significantly reduced the formation of insoluble protein aggregates, while adding the divalent metal zinc ion effectively suppressed the formation of soluble protein aggregates. The combination of the two yielded a spray-dried rhGH powder having insignificant protein degradation. Our data suggest that the two components might protect the protein through different mechanisms. Polysorbate molecules occupy the air-liquid interlace of spray droplets, thereby reducing the chance for rhGH to form insoluble aggregates by surface denaturation. Two zinc ions associate with two rhGH molecules to form a dimer complex that can resist the formation of soluble protein aggregates. Characterization of spray-dried powders by scanning electron microscopy suggests that both formulation and drying conditions have a strong influence on particle morphology and shape. Overall, spherical rhGH powders of smooth surface and good biochemical quality can be prepared by spray-drying using this formulation with no addition of sugar protectant.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 30 条
[21]  
2-H
[22]  
Macritchie F, 1978, Adv Protein Chem, V32, P283, DOI 10.1016/S0065-3233(08)60577-X
[23]  
Masters K., 1991, SPRAY DRYING HDB
[24]   FEASIBILITY STUDY ON SPRAY-DRYING PROTEIN PHARMACEUTICALS - RECOMBINANT HUMAN GROWTH-HORMONE AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
MUMENTHALER, M ;
HSU, CC ;
PEARLMAN, R .
PHARMACEUTICAL RESEARCH, 1994, 11 (01) :12-20
[25]  
OESWEIN JQ, 1990, RESP DRUG DEL 2 KEYS
[26]   OPTIMIZATION OF LYOPHILIZATION CONDITIONS FOR RECOMBINANT HUMAN INTERLEUKIN-2 BY DRIED-STATE CONFORMATIONAL-ANALYSIS USING FOURIER-TRANSFORM INFRARED-SPECTROSCOPY [J].
PRESTRELSKI, SJ ;
PIKAL, KA ;
ARAKAWA, T .
PHARMACEUTICAL RESEARCH, 1995, 12 (09) :1250-1259
[27]  
RANKELL AS, 1986, THEORY PRACTICE IND
[28]   Effects of bovine somatotropin (rbSt) concentration at different moisture levels on the physical stability of sucrose in freeze-dried rbSt/Sucrose mixtures [J].
Sarciaux, JME ;
Hageman, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :365-371
[29]  
THUROW H, 1984, DIABETOLOGIA, V27, P212
[30]  
TZANNIS ST, 1997, 213 ACS NAT M BIOT 2